High Tide Inc Dossier
|
SectorConsumer Discretionary IndustrySpecialty Retail Beta (adjusted)1.03 Intrinsic Value $1.73median of 3 methodsbased on filings through 31 Oct 2025 Market Price $2.67Price as of 1 Oct 2026 OvervaluedIntrinsic value is 35% below the market price −50% · IV below pricenear fair value ±15%IV above price · +50% Data confidence Sign in to view data confidence Market Cap $238M Enterprise Value $247.3M Shares Outstanding 82.2M diluted Moat Rating None Next Earnings Date28 Jan 2027 All prices and values are periodic snapshots, not live quotes. Source dates are shown for reference. ThesisStreet consensus, scenarios, merits, risks, and invalidation triggers Thesis Summary High Tide Inc. has successfully established itself as the leading retail-forward cannabis enterprise in Canada, leveraging a highly disruptive discount club model that has built a massive competitive moat. By transitioning customers into its Cabana Club and paid ELITE membership tiers, the company drives superior customer loyalty and higher-margin recurring revenue. Furthermore, High Tide's strategic international expansion—particularly through its majority-owned German subsidiary, Remexian Pharma—positions it to capture high-margin market share in Europe's rapidly growing medical cannabis sector. With the recent securing of a non-dilutive $40 million credit facility with the Bank of Montreal, High Tide is well-funded to execute its organic and M&A growth plans without diluting shareholders, making it a highly attractive growth play in a consolidating industry. This section is the 12-month view: analyst targets and the probability-weighted scenarios built from them. The intrinsic value at the top of this page answers a different question: what the business is worth today. Street view · analyst 12-month targets Low · most bearish analyst$4.00 Mean target$4.67 High · most bullish analyst$5.00 Street targets sit above today's price; our intrinsic value sits below it. Different horizons, different questions. Our research · scenarios, merits, risks, and invalidation triggersResearch as of 20 Jun 2026 Scenarios · 12-month scenario targets Bear CaseDownside scenario $4.5020% The bear case reflects persistent macroeconomic headwinds, consumer spending slowdowns, and intense price compression in the Canadian retail market. Same-store sales growth remains negative, putting pressure on brick-and-mortar margins. Regulatory delays in the U.S. or unexpected supply chain bottlenecks for German medical cannabis imports could stall international growth. If the company is forced to rely on promotional pricing to defend its 12% Canadian market share, EBITDA margins would compress, delaying the path to consistent GAAP net profitability. Base CaseCentral scenario $5.6750% The base case assumes steady execution of High Tide's domestic retail strategy, adding 20-30 stores annually to progress toward its long-term target of 350+ locations. Cabana Club and ELITE memberships grow at a moderate pace, stabilizing brick-and-mortar gross margins around 27-28%. Remexian maintains its strong position in Germany, distributing 7-8 tonnes of medical cannabis quarterly. Operating leverage continues to improve, leading to consistent positive adjusted EPS and sustainable free cash flow generation, supported by the new non-dilutive BMO credit facility. Bull CaseUpside scenario $7.2530% The bull case is driven by rapid expansion of the high-margin ELITE paid membership tier, faster-than-expected organic store rollouts in Canada, and explosive growth in Germany via Remexian Pharma. If Remexian continues to capture market share (exceeding 15%) and successfully introduces Canadian biomass imports to lower product costs, consolidated gross margins will expand significantly. Additionally, swift federal cannabis rescheduling in the United States would allow High Tide's established e-commerce and CBD platforms to rapidly transition into high-margin THC retail, unlocking a massive new addressable market. Scenarios are anchored to street consensus at the research date, with our probabilities and rationale. Key Investment Merits
Key Investment Risks
Thesis Invalidation Triggers
All scenarios are estimates and subject to change. Past performance is not indicative of future results. Quality Pillars MembersThis section is available to registered members. Create a free account or sign in to unlock the full breakdown. Explore this dossierValuationIntrinsic value, the six-method breakdown, peer medians, and your assumptions sandbox.Financial SnapshotRevenue, profitability, returns, balance sheet, dividends, and the filing-level detail.Qualitative AnalysisBusiness overview, strategic initiatives, and mergers, acquisitions & partnerships.Outlook & Key DatesForward estimates, reporting calendar, and the monitoring framework. |